Research Nester released a report titled “Alopecia Treatment Market: Global Demand Analysis & Opportunity Outlook 2027” which delivers detailed overview of the global alopecia treatment market in terms of market segmentation by disease, by drug, by gender, by route of administration, by distribution channel and by region.
Further, for the in-depth analysis, the report encompasses the industry growth drivers, restraints, supply and demand risk, market attractiveness, BPS analysis and Porter’s five force model.
The market for alopecia treatment is anticipated to grow at a CAGR of around 5.5% during the forecast period, i.e., 2019-2027. The market is segmented by disease, by drug, by gender, by route of administration, by distribution channel and by region, out of which, the disease segment is further segmented into androgenic alopecia, alopecia areata, alopecia totalis, alopecia universalis and others. Based on disease, the androgenic alopecia segment is estimated to observe the highest growth rate during the forecast period on account of higher incidence of this type of alopecia as compared with others. It was reported by the American Hair Loss Association that around 95% of hair loss cases among men can be credited to androgenic alopecia.
The growing research and development activities in North America are anticipated to substantially raise the market growth in the region, thereby justifying its highest share in the global market. Further, the increasing number of medications undergoing successful trials and receiving FDA approval are estimated to contribute towards the market growth. However, the market in Asia Pacific region is anticipated to witness the highest growth rate during the forecast period which can be attributed to the rising elderly population. Increasing cases of male and female pattern baldness in the region, mainly in countries such as China and India, are additional factors estimated to lead to the market growth.
Growing Geriatric Population to Drive the Growth of Alopecia Treatment Market
After a certain age, people, generally men, begin to lose hair which might be as a result of alopecia. This increases the demand for alopecia treatment products which is estimated to support the market growth during the forecast period. However, the high cost of medicines along with several possible side-effects of those medications is anticipated to restrict the growth of the market in the upcoming years.
This report also provides the existing competitive scenario of some of the key players of the global alopecia treatment market which includes company profiling of Histogen Inc., Cipla (CIPLA), Johnson & Johnson Limited (JNJ), Aclaris Therapeutics, Inc. (ACRS), Concert Pharmaceuticals (CNCE), Daiichi Sankyo Company Limited, Sun Pharmaceutical Industries Ltd. (SUNPHARMA), Capillus, RepliCel Life Sciences (RP) and HCell Inc. The profiling enfolds key information of the companies which encompasses business overview, products and services, key financials and recent news and developments. On the whole, the report depicts detailed overview of the global alopecia treatment market that will help industry consultants, equipment manufacturers, existing players searching for expansion opportunities, new players searching possibilities and other stakeholders to align their market centric strategies according to the ongoing and expected trends in the future.